Anupriya Patel inaugurates India Innovation Summit – Pioneering Solutions to End TB
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Experts urge early detection & better access to care
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
Announces Rs. 317 crore investment in new recycling plant
The study demonstrated equivalent efficacy, safety, immunogenicity, and pharmacokinetics between YESINTEK and the reference product Stelara
This addition strengthens Dr. Agarwals Eye Hospital's vast network of 28 hospitals across Karnataka and 220+ facilities worldwide
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine
Subscribe To Our Newsletter & Stay Updated